Patents

RECENT NEWS
newratings.com  Apr 10  Comment 
WASHINGTON (dpa-AFX) - Varian Medical Systems (VAR) said it has settled patent litigation with the University of Pittsburgh and the company will pay a lump sum of about $35 million to fully settle this matter. Varian said the settlement will be...
DailyFinance  Apr 10  Comment 
NEW YORK, NY and PETACH TIKVAH, ISRAEL -- (Marketwired) -- 04/10/14 -- BrainStorm Cell Therapeutics (OTCQB: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced that the U.S. Patent and...
DailyFinance  Apr 10  Comment 
DEERFIELD, IL -- (Marketwired) -- 04/10/14 -- Horizon Pharma, Inc. (NASDAQ: HZNP) today announced that Skyepharma has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for U.S. Patent Application 13/713,528...
DailyFinance  Apr 10  Comment 
SAN DIEGO, CA -- (Marketwired) -- 04/10/14 -- The U.S. District Court for the Southern District of California has denied a motion by Hospira, Inc. to stay Ivera's patent infringement lawsuit asserting infringement of three U.S. patents owned by...
TechCrunch  Apr 9  Comment 
 A bi-partisan Senate bill aimed at curbing abuse of the U.S. patent system has been handed another setback today, with Senate Judiciary Chairman Patrick Leahy (D-Vt.) announcing that, for the fourth time, consideration of the Patent Transparency...
DailyFinance  Apr 9  Comment 
Rudolph Technologies, Inc. (NYSE: RTEC), a leading provider of process characterization equipment, lithography equipment and software for wafer fabs and advanced packaging facilities, today announced another favorable ruling...
DailyFinance  Apr 9  Comment 
Filed under: Consumer Ally, Scandals and Lawsuits, Celebrities, Consumer Issues David Becker/Nightclub & Bar Media Group/Getty ImagesAdam Carolla is defending his popular podcast. I'm going to tell you a secret. When I was a child, I was...
Benzinga  Apr 9  Comment 
Broadridge Financial Solutions, Inc. (NYSE: BR), the financial services industry's leading provider of investor communications services, announced recently that it has bolstered its intellectual property portfolio with the addition of U.S. Patent...
DailyFinance  Apr 8  Comment 
LAS VEGAS, NV -- (Marketwired) -- 04/08/14 -- Amazonica Corp. (OTCQB: AMZZ) (OTCBB: AMZZ) ("Amazonica" or the "Company"), is pleased to announce that it has completed the filing of a combustion mixture patent for its ultra-pure hydrogen...
DailyFinance  Apr 8  Comment 
The United States Court of Appeals for the Federal Circuit has issued its decision in Rovi’s patent infringement litigation against Amazon Inc. Rovi (NASDAQ:ROVI) had sued Amazon in United States District Court for the...




 
TOP CONTRIBUTORS

Patents

Patent is the right to ownership,as part of an intellectual property law, where by a person / organization discovers a lesser known concept or invents something new and holds sole intellectual ownership rights to that particular idea. These are usually published / granted after a lot of research and exhaustive verification. Patents are generally registered with United States Patent and Trademark Office, an Agency Of The United States Department Of Commerce, in the United States and The Intellectual Property Office,a division of the Department for Innovation, Universities & Skills in the United Kingdom.

Technological Patents

Pharmaceutical Patents

Pharmaceutical patents protect manufacturers of prescription drugs, prohibiting others from producing a drug during the length of its patent protection. The length of these patents varies in different countries, though they are usually between 15-20 years. In the U.S., a pharmaceutical patent is valid for 20 years. Drug companies usually apply for patent protection before they actually begin producing the drug, opting instead to secure their rights to a particular compound at the beginning of the testing process. By the time a drug comes to market, there may only be 8-10 years of patent protection remaining, which is significantly less than the 20 offered by the patent. Companies often attempt to extend these patents by making slight reformulations of the original compound or proving its effectiveness at treating a condition other than the one for which it was originally granted a patent. This is referred to as "evergreening", a practice which many criticize.

For further information on the process of obtaining pharmaceutical patents and regulatory approval, see Clinical Trials and FDA Approval.

For more information about pharmaceutical patents in relation to generic versions of drugs, see Generic Drugs.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki